Cornerstone Investment Partners’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$207K	Buy	+1,825	New	+$207K	0.01%	159
2025 Q1	–	Sell	-1,984	Closed	-$213K	–	233
2024 Q4	$213K	Buy	+1,984	New	+$213K	0.01%	183